RKI-1313

CAS No. 1342276-76-9

RKI-1313( RKI-1313 | RKI 1313 | RKI1313 )

Catalog No. M11371 CAS No. 1342276-76-9

RKI-1313 was a selective inhibitor for ROCK-dependent signaling, cytoskeletal changes, anchorage-independent colony formation, migration, and invasion.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 155 In Stock
5MG 138 In Stock
10MG 207 In Stock
25MG 369 In Stock
50MG 528 In Stock
100MG 755 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    RKI-1313
  • Note
    Research use only, not for human use.
  • Brief Description
    RKI-1313 was a selective inhibitor for ROCK-dependent signaling, cytoskeletal changes, anchorage-independent colony formation, migration, and invasion.
  • Description
    RKI-1313 was a selective inhibitor for ROCK-dependent signaling, cytoskeletal changes, anchorage-independent colony formation, migration, and invasion.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    RKI-1313 | RKI 1313 | RKI1313
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    ROCK
  • Recptor
    ROCK1| ROCK2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1342276-76-9
  • Formula Weight
    340.4
  • Molecular Formula
    C17H16N4O2S
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in DMSO
  • SMILES
    O=C(NC1=NC(C2=CC=NC=C2)=CS1)NCC3=CC=CC(OC)=C3
  • Chemical Name
    1-(3-Methoxybenzyl)-3-[4-(pyridin-4-yl)thiazol-2-yl]urea

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Patel RA, et al. Y Res. 2012 Oct 1;72(19): 5025-34.
molnova catalog
related products
  • CKI-7

    CKI-7 2HCl is a potent and ATP-competitive inhibitor of casein kinase 1 (CK1; IC50: 6 μM; Ki: 8.5 μM) and a selective Cdc7 kinase inhibitor.

  • NSC 409012

    NSC 409012 is an active compound.

  • Cucurbitacin A

    Cucurbitacin I, cytotoxic triterpenoid sterols isolated from plants, elicits the formation of actin/phospho-myosin II co-aggregates by stimulation of the RhoA/ROCK pathway and inhibition of LIM-Kinase.